The QB3 Bridging-the-Gap Awards
This year the format of the Bridging-the-Gap Awards has changed. Preference is still given to work that could lead to a potential diagnostic or therapeutic outcome within the timespan of a few years. However, this year the awards will focus on neurodegenerative diseases—and, in particular, on researchers whose work is not currently focused on such diseases, but whose technologies or concepts could bring new insights into their treatment. Collaborations with neurodegenerative disease specialists are acceptable.
The deadline for applications is Friday, October 17, 2014.
Submit an application
QB3 believes there is a funding gap between NIH-based traditional research funding and startup commercial funding. To help address this funding gap, and the research that languishes between these sources of funding, we created the QB3 Bridging-the-Gap awards with generous support from the Rogers Family Foundation and other sources.
Awards are for $100,000 per year. An additional $25,000 award will be made to groups who achieve their proposed goals within the year. A second year of funding is available based on progress. Each award includes membership in the QB3 Startup in a Box program and QB3 staff will work with the team to identify potential funders and collaborators for the next steps.
Read our 2013 report The QB3 Bridging-the-Gap Awards: a story of success
The QB3 Bridging-the-Gap committee looks for projects that are capable of yielding practical benefit to society within a reasonable time frame. The committee looks for projects that are at a stage where early proof-of-concept experiments funded by the award will assist the group in lowering the technical risk for a given technology. It is hoped that these groups could form a startup company within a 1-3 year period.
The applications that best fit the goals of this award will be selected by a QB3 committee, and finalists will give an oral presentation to the awards committee, who will make a final decision.
Questions? Email Neena Kadaba.